Shows / Peptides Weekly
Peptides Weekly
What peptides are, what the evidence actually shows, and what is approved, investigational or unregulated. Every Thursday: the week in peptide science and regulation, and one peptide explained properly — mechanism, studies, status, risks. Education only; never dosing, sourcing or protocols, and never medical advice. AI Disclosure: This podcast is curated by Patrick but uses AI-generated voice synthesis for audio production.
Episodes
- Peptides Weekly
Ep 7: A coroner links a 75-year-old's cardiac arrest to CJC-1295 and ipamorelin.
Peptides Weekly A coroner links a 75-year-old's cardiac arrest to CJC-1295 and ipamorelin. What You Need to Know: A Victorian coroner has linked actor Richard…
- Peptides Weekly
Ep 6: Thirty-nine percent of GLP-1 users reported nail detachment, versus nine percent of controls.
Peptides Weekly Thirty-nine percent of GLP-1 users reported nail detachment, versus nine percent of controls. What You Need to Know: In a cross-sectional…
- Peptides Weekly
Ep 5: Three to four extra rare vision-loss cases per ten thousand showed up in an observational…
Peptides Weekly Three to four extra rare vision-loss cases per ten thousand showed up in an observational GLP-1 study. What You Need to Know: Three to four…
- Peptides Weekly
Ep 4: Unapproved peptides could reach temporary sale while treatment claims are still not fully…
Peptides Weekly Unapproved peptides could reach temporary sale while treatment claims are still not fully safety tested. What You Need to Know: Unapproved…
- Peptides Weekly
Ep 3: Nail detachment was over four times more common in people using GLP-1 drugs.
Peptides Weekly Nail detachment was over four times more common in people using GLP-1 drugs. What You Need to Know: A controlled study found nail detachment…
- Peptides Weekly
Ep 2: Nearly one in six children taking GLP-1 drugs show nutritional deficiencies in a new study.
Peptides Weekly Nearly one in six children taking GLP-1 drugs show nutritional deficiencies in a new study. What You Need to Know: A retrospective analysis…
- Peptides Weekly
Ep 1: Phase 3 results for an investigational amylin peptide medicine in diabetes and obesity were…
Peptides Weekly Phase 3 results for an investigational amylin peptide medicine in diabetes and obesity were released this week. What You Need to Know: Novo…